Orange Book product · Generic (ANDA)
ETHRIL 250
ERYTHROMYCIN STEARATE
At a glance
Approved Prior to Jan 1, 1982
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
ERYTHROMYCIN STEARATE
Strength
EQ 250MG BASE
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 061605
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ERYTHROMYCIN STEARATE
- 1990ERYTHROMYCIN STEARATEGeneric (ANDA)
ANDA 063179 · ANI PHARMS
- —BRISTAMYCINGeneric (ANDA)
ANDA 061304 · BRISTOL
- —BRISTAMYCINGeneric (ANDA)
ANDA 061887 · BRISTOL
- —ERYPARGeneric (ANDA)
ANDA 062032 · PARKE DAVIS
- —ERYPARGeneric (ANDA)
ANDA 062322 · WARNER CHILCOTT
- —ERYTHROCIN STEARATEGeneric (ANDA)
ANDA 060359 · AZURITY
- —ERYTHROMYCIN STEARATEGeneric (ANDA)
ANDA 061461 · ANI PHARMS
- —ERYTHROMYCIN STEARATEGeneric (ANDA)
ANDA 061591 · ANI PHARMS
- —ERYTHROMYCIN STEARATEGeneric (ANDA)
ANDA 062089 · LEDERLE
- —ERYTHROMYCIN STEARATEGeneric (ANDA)
ANDA 061505 · PHARMOBEDIENT
- —ERYTHROMYCIN STEARATEGeneric (ANDA)
ANDA 061743 · PUREPAC PHARM
- —ERYTHROMYCIN STEARATEGeneric (ANDA)
ANDA 062121 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
